Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Management of central nervous system teratoma. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia Zygourakis, C. C., Davis, J. L., Kaur, G. n., Ames, C. P., Gupta, N. n., Auguste, K. I., Parsa, A. T. 2015; 22 (1): 98–104

Abstract

Central nervous system (CNS) teratomas are very rare neoplasms that contain tissues derived from all three germ cell layers (endoderm, mesoderm, and ectoderm). Patients with teratomas usually have a good prognosis. Given the paucity of cases in the literature, we present a retrospective review of 15 CNS teratomas treated over a 25 year period at the University of California, San Francisco. We describe the presentation, location, treatment, and adjuvant therapy for these patients, and highlight three unique cases that emphasize the diverse presentation and treatment of these rare tumors.

View details for PubMedID 25150764